See more
Can you buy stock in Novavax?
Fund your account. Research the stock. Find the stock by name or ticker symbol – NVAX – and research it before deciding if it's a good investment for you. Purchase now or later.
What is the prediction for Novavax stock?
The 6 analysts offering 12-month price forecasts for Novavax Inc have a median target of 165.50, with a high estimate of 207.00 and a low estimate of 35.00. The median estimate represents a +180.65% increase from the last price of 58.97.
Who owns the most Novavax stock?
The Vanguard Group, Inc.Top 10 Owners of Novavax IncStockholderStakeShares ownedThe Vanguard Group, Inc.8.79%6,868,884BlackRock Fund Advisors4.64%3,626,649SSgA Funds Management, Inc.3.19%2,495,542Susquehanna Financial Group LLLP1.70%1,331,1186 more rows
Why are the Novavax shares falling?
The company is mired in annual losses, a trend that continued last year. In 2021, Novavax lost $23.44 per share, widening from a per-share loss of $7.27 in 2020. Analysts expected a loss of $13.70 per share in 2021. This year, analysts expect Novavax to become profitable with per-share earnings of $25.
Will NVAX stock go up tomorrow?
Tomorrow's movement Prediction of Novavax, Inc. NVAX as on 20 Jul 2022 appears strongly Bullish. This stock started moving upwards as soon as it opened....Munafa value: 65 as on 20 Wed Jul 2022.Upside target67.66Upside target63.61Upside target61.17Upside target60.46Downside target56.535 more rows
Is Novavax a buy Zacks?
How good is it? See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
What ETF has Nvax in it?
The largest ETF holder of NVAX is the SPDR S&P Biotech ETF (XBI), with approximately 820.00K shares. Investors may also find of interest that the ETF with the largest allocation to NVAX stock is IQ U.S. Mid Cap R&D Leaders ETF (MRND), with a portfolio weight of 3.82%.
Who are Novavax shareholders?
Our data shows that The Vanguard Group, Inc. is the largest shareholder with 9.0% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 6.5% and 2.8%, of the shares outstanding, respectively.
Who are the major shareholders of Vanguard Group?
Top 10 Owners of American Vanguard CorpStockholderStakeShares bought / soldThe Vanguard Group, Inc.5.65%+26,521T. Rowe Price Associates, Inc. (I...4.77%-341,474Wellington Management Co. LLP4.65%-40,729SSgA Funds Management, Inc.3.34%+78,4096 more rows
Is Nvax a good buy now?
Only two recommend Novavax as a strong buy. But there's another piece of data that bolsters the argument that analysts are actually very bullish about Novavax. The consensus Wall Street 12-month price target for Novavax is $158.67. That's nearly 3.4 times the current share price.